MORPHINE Safety Questions, MORPHINE Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about MORPHINE. Our extensive database of MORPHINE adverse events and MORPHINE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about MORPHINE

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




MORPHINE Safety Reports

Total MORPHINE reports: 473.
MORPHINE FDA safety alerts: 2002 2003 2005 2007 .
Reported deaths: 162    Reported hospitalizations: 144.
Take MORPHINE Side Effects Survey or Share Your MORPHINE Story. Read More Here.

Showing 1-75 of 473 Next >

Consumer or non-health professional from UNITED STATES reported MORPHINE problem on Dec 13, 2005. Male patient, weighting 362.0 lb, was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: respiratory arrest. MORPHINE dosage: 2 MG, PCA DOSE 10 MIN LOCKOUT 1.5MG/HR. Patient recovered.

MORPHINE problem was reported by a Health Professional from UNITED STATES on Dec 12, 2005. Male patient, 74 years of age, was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, overdose. MORPHINE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported MORPHINE problem on Mar 06, 2006. Male patient, 76 years of age, was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: overdose, unresponsive to stimuli. MORPHINE dosage: 2 MG PCA DOSE AND 20MG 4 HR LIMIT, INTRAVENOUS. Patient recovered.

MORPHINE problem was reported by a Health Professional from UNITED STATES on June 12, 2006. Female patient was diagnosed with postoperative care, spinal fusion surgery and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: respiratory arrest. MORPHINE dosage: 2 MG, 10 MIN LOCKOUT, INTRAVENOUS. During the same period patient was treated with MORPHINE SULPHATE, LACTATED RINGER. Patient recovered.

Pharmacist from UNITED STATES reported MORPHINE problem on July 20, 2006. Female patient, 38 years of age, was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, overdose. MORPHINE dosage: 12 MG, 1 IN 1HR, INTRAVENOUS. During the same period patient was treated with IMITREX. Patient recovered.

MORPHINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 04, 2006. Female patient was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, overdose. MORPHINE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported MORPHINE problem on Nov 02, 2005. Female patient, child 8 years of age, weighting 55.12 lb, was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: respiratory arrest. MORPHINE dosage: unknown. During the same period patient was treated with DEPAKOTE, ANTIBIOTICS. Patient died on 10/25/2001.

MORPHINE problem was reported by a Health Professional from UNITED STATES on Mar 02, 2007. Male patient, 47 years of age, was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: device related infection, diplegia, infusion site abscess, infusion site mass, spinal cord compression, streptococcal infection. MORPHINE dosage: 32 MG, 1 IN D, INTRATHECAL. Patient recovered.

Health Professional from UNITED STATES reported MORPHINE problem on Mar 21, 2007. Male patient, 35 years of age, weighting 200.0 lb, was diagnosed with pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: pruritus. MORPHINE dosage: 2MG IV. Patient recovered.

MORPHINE problem was reported by a Consumer or non-health professional from on Mar 16, 2007. Female patient, 77 years of age, was diagnosed with dyspnoea and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, delusion of replacement. MORPHINE dosage: unknown. During the same period patient was treated with DIGOXIN, FUROSEMIDE, METOLAZONE, POTASSIUM ACETATE, SPIRONOLACTONE, WARFARIN, OXYGEN. Patient died.

Health Professional from UNITED STATES reported MORPHINE problem on Mar 13, 2007. Male patient, 47 years of age, was diagnosed with back pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: injection site mass, injection site nodule, intraspinal abscess, streptococcal infection. MORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.

MORPHINE problem was reported by a Consumer or non-health professional from on Mar 23, 2007. Female patient, 78 years of age, was diagnosed with induction of anaesthesia, intubation and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: delayed recovery from anaesthesia, miosis, respiratory depression. MORPHINE dosage: unknown. During the same period patient was treated with FENTANYL, MIDAZOLAM, PROPOFOL, ROCURONIUM BROMIDE, SEVOFLURANE, CYCLIZINE, HARTMANN, SUCCINYLATED GELATIN. Patient recovered.

Physician from UNITED STATES reported MORPHINE problem on Mar 20, 2007. Male patient, 55 years of age, was diagnosed with pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: granuloma. MORPHINE dosage: unknown. Patient recovered.

MORPHINE problem was reported by a Physician from UNITED STATES on Mar 20, 2007. Male patient, 45 years of age, was diagnosed with back pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: granuloma. MORPHINE dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported MORPHINE problem on Mar 28, 2007. Male patient, 53 years of age, weighting 182.5 lb, was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: urticaria. MORPHINE dosage: unknown. During the same period patient was treated with DIATRIZOATE MEGLUMINE, CITALOPRAM HYDROBROMIDE, FOLIC ACID, THIAMINE, FAMCICLOVIR, FLUNISOLIDE. Patient recovered.

MORPHINE problem was reported by a Pharmacist from UNITED STATES on Mar 28, 2007. Male patient, 53 years of age, weighting 254.0 lb, was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: pruritus, urticaria. MORPHINE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported MORPHINE problem on Mar 20, 2007. Male patient, 58 years of age, was diagnosed with cancer pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, neoplasm malignant. MORPHINE dosage: unknown. Patient died on 11/26/2006.

MORPHINE problem was reported by a Consumer or non-health professional from on Mar 26, 2007. Male patient, 64 years of age, was diagnosed with cancer pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: hallucination, unresponsive to stimuli. MORPHINE dosage: 1.5 ML/HR. During the same period patient was treated with METHOTREXAT. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported MORPHINE problem on Apr 04, 2007. Male patient, 49 years of age, was diagnosed with pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, respiratory depression. MORPHINE dosage: 200MG Q12H PO. Patient recovered.

MORPHINE problem was reported by a Pharmacist from UNITED STATES on Apr 04, 2007. Male patient, 67 years of age, weighting 196.2 lb, was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: injection site erythema, pain in extremity. MORPHINE dosage: unknown. During the same period patient was treated with NITROGLYCERIN OINT, PROTONIX, ATENOLOL, REGLAN, LORAZEPAM, ACETAMINOPHEN AND HYDROCODONE BITARTRATE, ONDANSETRON. Patient recovered.

Pharmacist from UNITED STATES reported MORPHINE problem on Apr 05, 2007. Male patient, 56 years of age, was diagnosed with pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, hypotension, mental status changes, tachycardia. MORPHINE dosage: 7 MG IV OTU. Patient recovered.

MORPHINE problem was reported by a Health Professional from UNITED STATES on Apr 04, 2007. Female patient, 27 years of age, was diagnosed with neuralgia and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: irritability, overdose, pain, renal impairment. MORPHINE dosage: 30 MG, QID. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported MORPHINE problem on Mar 27, 2007. Male patient, 50 years of age, was diagnosed with back pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: delusion, encephalopathy, hallucination, hypertensive crisis. MORPHINE dosage: unknown. Patient recovered.

MORPHINE problem was reported by a Physician from UNITED STATES on Mar 21, 2007. Male patient, 52 years of age, weighting 215.0 lb, was diagnosed with procedural pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: arthralgia, dyskinesia, hallucination, pain in extremity. MORPHINE dosage: 30 MG, Q12H, ORAL. During the same period patient was treated with TRAMADOL, TRIAMTERENE AND HYDROCHLOROTHIAZID, PAXIL, NEURONTIN, DILAUDID, VALIUM. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported MORPHINE problem on Apr 09, 2007. Male patient, 77 years of age, weighting 145.9 lb, was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: nausea, vomiting. MORPHINE dosage: unknown. Patient recovered.

MORPHINE problem was reported by a Health Professional from UNITED STATES on Apr 06, 2007. Female patient, 27 years of age, was diagnosed with diabetic neuropathy, smoker, neuralgia, diabetes mellitus insulin-dependent, alcohol use and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: irritability, overdose, pain, renal failure. MORPHINE dosage: 30 MG, QID. During the same period patient was treated with ALBUTEROL, NEURONTIN, INSULIN, ALCOHOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported MORPHINE problem on Apr 10, 2007. Female patient, 33 years of age, was diagnosed with pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: cognitive disorder, constipation, post lumbar puncture syndrome, sedation. MORPHINE dosage: unknown. Patient recovered.

MORPHINE problem was reported by a Pharmacist from UNITED STATES on Apr 10, 2007. Female patient was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. MORPHINE dosage: unknown. During the same period patient was treated with DEMEROL. Patient recovered.

Pharmacist from UNITED STATES reported MORPHINE problem on Apr 13, 2007. Male patient, weighting 124.0 lb, was diagnosed with prostate cancer metastatic, metastases to bone and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: bone pain, cancer pain, diarrhoea, discomfort, loss of consciousness, overdose, respiratory depression. MORPHINE dosage: 45MG SR BID PO. Patient died on 02/26/2007.

MORPHINE problem was reported by a Consumer or non-health professional from on Apr 13, 2007. Male patient, 60 years of age, was diagnosed with analgesic effect, inguinal hernia repair, laparoscopic surgery and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: acidosis, grand mal convulsion, hypercapnia, respiratory rate decreased, subcutaneous emphysema. MORPHINE dosage: unknown. During the same period patient was treated with CARBON DIOXIDE, CARBON DIOXIDE. Patient recovered.

Pharmacist from UNITED STATES reported MORPHINE problem on Apr 16, 2007. Male patient was diagnosed with pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. MORPHINE dosage: 10MG ADMINISTERED ONCE IT. Patient recovered.

MORPHINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Female patient was diagnosed with pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: dyspnoea. MORPHINE dosage: 15 MG QD X 2 DAYS. Patient died on 01/10/2007.

Consumer or non-health professional from reported MORPHINE problem on Apr 19, 2007. Male patient, 17 years of age, was treated with MORPHINE. MORPHINE dosage: unknown. Patient died on 04/15/2007.

MORPHINE problem was reported by a Pharmacist from UNITED STATES on Apr 26, 2007. Male patient, 60 years of age, weighting 188.9 lb, was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: dizziness, nausea, vomiting. MORPHINE dosage: unknown. During the same period patient was treated with AMOXICILLIN, BUPROPION, TRAZODONE, FLUOXETINE, OMEPRAZOLE, FENTANYL, ACETAMINOPHEN, CHLORHEXIDINE GLUCONATE. Patient recovered.

Consumer or non-health professional from reported MORPHINE problem on Apr 18, 2007. Female patient, 80 years of age, was diagnosed with pain, breakthrough pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, balance disorder, chest pain, hallucination, visual, restlessness, vomiting. MORPHINE dosage: unknown. During the same period patient was treated with OXYCODONE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

MORPHINE problem was reported by a Consumer or non-health professional from on Apr 18, 2007. Male patient, 58 years of age, was diagnosed with pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: confusional state, constipation, faecaloma, intestinal perforation, libido decreased, overdose, somnolence, weight increased. MORPHINE dosage: unknown. Patient recovered.

Consumer or non-health professional from reported MORPHINE problem on Apr 18, 2007. Male patient, 58 years of age, was diagnosed with pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: confusional state, constipation, faecaloma, intestinal perforation, libido decreased, overdose, somnolence, weight increased. MORPHINE dosage: unknown. Patient recovered.

MORPHINE problem was reported by a Consumer or non-health professional from on Apr 18, 2007. Female patient, 60 years of age, was diagnosed with palliative care, depression and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, body temperature increased, calcium ionised increased, confusional state, oxygen saturation decreased, respiratory rate decreased, rhonchi, somnolence. MORPHINE dosage: unknown. During the same period patient was treated with AMITRIPTYLINE, TRAZODONE, BROMAZEPAM. Patient recovered.

Physician from reported MORPHINE problem on May 03, 2007. Male patient, 41 years of age, weighting 158.7 lb, was diagnosed with ear infection, sleep disorder, ear pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: cardiac valve disease, overdose, pulmonary oedema. MORPHINE dosage: unknown. During the same period patient was treated with SUBUTEX, AMOXICILLIN, DIHYDROCODEINE BITARTRATE, DOTHIEPIN HYDROCHLORIDE, IBUPROFEN, LOCORTEN. Patient died on 11/29/2005.

MORPHINE problem was reported by a Health Professional from UNITED STATES on Apr 12, 2007. Male patient, 47 years of age, was diagnosed with back pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: injection site mass, intraspinal abscess, streptococcal infection. MORPHINE dosage: 32 MG, DAILY. During the same period patient was treated with MORPHINE SULPHATE. Patient was hospitalized and became disabled. Patient recovered.

Consumer or non-health professional from UNITED STATES reported MORPHINE problem on May 01, 2007. Female patient, 41 years of age, weighting 190.0 lb, was diagnosed with back pain, fibromyalgia and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: overdose. MORPHINE dosage: unknown. Patient recovered.

MORPHINE problem was reported by a Consumer or non-health professional from UNITED STATES on May 03, 2007. Male patient, 54 years of age, was diagnosed with pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: angioedema, rash. MORPHINE dosage: 60 MG BID PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported MORPHINE problem on May 07, 2007. Male patient, 71 years of age, was diagnosed with back pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: mental status changes. MORPHINE dosage: 90MG QD PO. Patient was hospitalized. Patient recovered.

MORPHINE problem was reported by a Consumer or non-health professional from on May 02, 2007. Male patient, 41 years of age, weighting 158.7 lb, was diagnosed with ear infection, sleep disorder, ear pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: aortic valve calcification, aortic valve stenosis, left ventricular hypertrophy, overdose, pulmonary oedema. MORPHINE dosage: unknown. During the same period patient was treated with SUBUTEX, AMOXICILLIN, DIHYDROCODEINE BITARTRATE, DOTHIEPIN HYDROCHLORIDE, IBUPROFEN, LOCORTEN. Patient died on 11/29/2005.

Consumer or non-health professional from reported MORPHINE problem on May 03, 2007. Female patient, 35 years of age, was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: agitation, anaphylactic shock, chills, intentional overdose, rash, somnolence. MORPHINE dosage: unknown. During the same period patient was treated with LEXOMIL. Patient was hospitalized. Patient recovered.

MORPHINE problem was reported by a Physician from AUSTRALIA on May 10, 2007. Female patient, 61 years of age, was diagnosed with multiple myeloma and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: bone disorder, osteonecrosis, pain in jaw, toothache. MORPHINE dosage: unknown. During the same period patient was treated with ZOMETA, STEROIDS NOS. Patient recovered.

Health Professional from UNITED STATES reported MORPHINE problem on May 14, 2007. Male patient, 50 years of age, weighting 235.0 lb, was diagnosed with chest pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: chest pain. MORPHINE dosage: 2MG PRN IVP. Patient recovered.

MORPHINE problem was reported by a Physician from UNITED STATES on Apr 30, 2007. Male patient, 55 years of age, was diagnosed with analgesic effect, muscle spasms and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: granuloma, spinal cord compression. MORPHINE dosage: unknown. During the same period patient was treated with MORPHINE SULPHATE, MORPHINE SULPHATE, MORPHINE SULPHATE. Patient recovered.

Physician from UNITED STATES reported MORPHINE problem on Apr 30, 2007. Male patient, 45 years of age, was diagnosed with back disorder and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: catheter related complication, fibroma, granuloma, spinal cord compression, spinal cord neoplasm. MORPHINE dosage: unknown. Patient recovered.

MORPHINE problem was reported by a Consumer or non-health professional from on May 08, 2007. Male patient, 82 years of age, was diagnosed with dyspnoea, chronic obstructive pulmonary disease and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: confusional state, constipation, dehydration, eating disorder, sepsis, somnolence, urinary tract infection, vomiting. MORPHINE dosage: 20 MG, Q12H. During the same period patient was treated with MORPHINE SULPHATE, MORPHINE SULPHATE, OXYGEN, CORTICOSTEROIDS. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported MORPHINE problem on May 14, 2007. Female patient, 74 years of age, was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: bronchospasm, respiratory acidosis. MORPHINE dosage: 60 MG, DAILY. During the same period patient was treated with SEVREDOL, VALIUM, LIORESAL, DEROXAT, DAFALGAN, IRBESARTAN, GINKORT, RIVOTRIL. Patient recovered.

MORPHINE problem was reported by a Consumer or non-health professional from on May 16, 2007. Male patient, 62 years of age, was diagnosed with pain, psoriasis and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: constipation, dehydration, diarrhoea, impaired healing, insomnia, oral intake reduced, pain in extremity. MORPHINE dosage: unknown. During the same period patient was treated with NEOTIGASON, BECLOMETHASONE DIPROPIONATE, CAPASAL, COAL TAR, MIRTAZAPINE. Patient was hospitalized. Patient recovered.

Physician from reported MORPHINE problem on May 16, 2007. Male patient, 62 years of age, was diagnosed with pain, psoriasis and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: bone pain, constipation, dehydration, diarrhoea, enthesopathy, impaired healing, insomnia, mobility decreased, neck pain. MORPHINE dosage: unknown. During the same period patient was treated with NEOTIGASON, BECLOMETHASONE DIPROPIONATE, CAPASAL, COAL TAR, MIRTAZAPINE, OLANZAPINE, PARAFFIN, SALBUTAMOL. Patient was hospitalized and became disabled. Patient recovered.

MORPHINE problem was reported by a Consumer or non-health professional from on May 07, 2007. Male patient, 60 years of age, was diagnosed with pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: acidosis, grand mal convulsion, respiratory rate decreased, subcutaneous emphysema. MORPHINE dosage: 20 MG, SEE TEXT. During the same period patient was treated with ANAESTHETICS. Patient recovered.

Consumer or non-health professional from reported MORPHINE problem on May 22, 2007. Male patient, 38 years of age, weighting 551.2 lb, was diagnosed with maintenance of anaesthesia and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: hypercapnia, loss of consciousness, obstructive airways disorder. MORPHINE dosage: unknown. During the same period patient was treated with PARACETAMOL, DESFLURANE, REMIFENTANIL, ROCURONIUM BROMIDE. Patient recovered.

MORPHINE problem was reported by a Pharmacist from UNITED STATES on May 24, 2007. Female patient, 72 years of age, weighting 111.3 lb, was diagnosed with pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: blood ph decreased, loss of consciousness, mental status changes, miosis, pco2 increased, po2 decreased, respiratory depression, respiratory rate decreased, sedation. MORPHINE dosage: 60MG BID PO. During the same period patient was treated with MORPHINE SULPHATE SOLUABLE. Patient recovered.

Consumer or non-health professional from reported MORPHINE problem on May 24, 2007. Male patient, 43 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: colitis, gastrointestinal hypomotility. MORPHINE dosage: unknown. During the same period patient was treated with CAPECITABINE, PACLITAXEL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

MORPHINE problem was reported by a Physician from UNITED KINGDOM on May 15, 2007. Male patient, 60 years of age, was diagnosed with laparoscopic surgery and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: acidosis, grand mal convulsion, hypercapnia, post procedural complication, respiratory rate decreased, subcutaneous emphysema. MORPHINE dosage: 20 MG, INTRAVENOUS. During the same period patient was treated with CARBON DIOXIDE. Patient recovered.

Pharmacist from UNITED STATES reported MORPHINE problem on May 30, 2007. Male patient, 63 years of age, was diagnosed with pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, heart rate increased, sedation, unresponsive to stimuli. MORPHINE dosage: unknown. During the same period patient was treated with LORAZEPAM. Patient was hospitalized. Patient recovered.

MORPHINE problem was reported by a Pharmacist from UNITED STATES on May 31, 2007. Male patient, 42 years of age, was diagnosed with neuralgia and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hypoventilation, loss of consciousness, oxygen saturation decreased, somnolence. MORPHINE dosage: unknown. During the same period patient was treated with BACLOFEN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported MORPHINE problem on June 04, 2007. Male patient, 50 years of age, weighting 235.0 lb, was diagnosed with chest pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: chest pain, feeling abnormal. MORPHINE dosage: 2MG PRN IVP. Patient recovered.

MORPHINE problem was reported by a Consumer or non-health professional from on June 04, 2007. Female patient, weighting 5.51 lb, was diagnosed with pain, epidural anaesthesia and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: neonatal disorder, respiratory arrest. MORPHINE dosage: unknown. During the same period patient was treated with LOCAL ANESTHETIC. Patient recovered.

Pharmacist from UNITED STATES reported MORPHINE problem on June 07, 2007. Male patient, 60 years of age, was diagnosed with pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, lethargy, mental status changes, respiratory depression. MORPHINE dosage: 30MG BID PO. During the same period patient was treated with OXYCODONE. Patient was hospitalized. Patient recovered.

MORPHINE problem was reported by a Pharmacist from UNITED STATES on June 12, 2007. Female patient was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: bradycardia, circulatory collapse, eye rolling, overdose, respiratory arrest, skin discolouration, tongue disorder. MORPHINE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported MORPHINE problem on June 05, 2007. Female patient, 48 years of age, was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. MORPHINE dosage: unknown. Patient died on 01/01/2003.

MORPHINE problem was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2007. Female patient, 25 years of age, was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. MORPHINE dosage: unknown. During the same period patient was treated with BENZODIAZEPINE, AMPHETAMINE. Patient died on 01/01/2003.

Consumer or non-health professional from UNITED STATES reported MORPHINE problem on June 05, 2007. Female patient, 17 years of age, was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. MORPHINE dosage: unknown. Patient died on 01/01/2003.

MORPHINE problem was reported by a Pharmacist from UNITED STATES on June 12, 2007. Male patient, 76 years of age, weighting 185.0 lb, was diagnosed with chest pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: injection site irritation, injection site pain. MORPHINE dosage: 4MG X1 IV. Patient recovered.

Consumer or non-health professional from UNITED STATES reported MORPHINE problem on June 05, 2007. Female patient, 51 years of age, was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. MORPHINE dosage: unknown. During the same period patient was treated with VENLAFAXINE, COCAINE. Patient died on 01/01/2003.

MORPHINE problem was reported by a Consumer or non-health professional from on June 12, 2007. Female patient, 40 years of age, was diagnosed with back pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, accidental overdose, acidosis, cognitive disorder, faecal incontinence, headache, hypoxia, leukoencephalopathy, loss of consciousness. MORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported MORPHINE problem on May 31, 2007. Female patient, 40 years of age, was diagnosed with pain management and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: fall, international normalised ratio increased, pain. MORPHINE dosage: unknown. During the same period patient was treated with LIQUID OXYDOSE, CIPRO, VFEND. Patient was hospitalized. Patient recovered.

MORPHINE problem was reported by a Pharmacist from UNITED STATES on June 19, 2007. Male patient, 88 years of age, weighting 244.7 lb, was diagnosed with pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: pruritus. MORPHINE dosage: 30MG BID PO. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported MORPHINE problem on June 20, 2007. Male patient, 74 years of age, was diagnosed with pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: myoclonus. MORPHINE dosage: 400MG BID PO. Patient was hospitalized. Patient recovered.

MORPHINE problem was reported by a Pharmacist from UNITED STATES on June 20, 2007. Male patient, 61 years of age, was diagnosed with pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: accidental overdose, confusional state, depressed level of consciousness, sedation. MORPHINE dosage: 60MG TID PO. During the same period patient was treated with OXYCODONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported MORPHINE problem on June 21, 2007. Female patient was diagnosed with procedural pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: apnoea, obstructive airways disorder, pulse absent. MORPHINE dosage: 2 MG BOLUS EVERY 8 MIN WITH 1-MG/H INFUSION. Patient died.

Showing 1-75 of 473 Next >

Ask Our Patient Community about MORPHINE

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
Prinivil